Rockefeller Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.9M Buy
1,338,592
+576,095
+76% +$13.1M 0.05% 325
2026
Q1
$16.3M Buy
762,497
+168,146
+28% +$3.5M 0.03% 508
2025
Q4
$12.7M Buy
594,351
+529,367
+815% +$10.8M 0.02% 576
2025
Q3
$1.09M Buy
+64,984
New +$974K ﹤0.01% 1389
2023
Q1
Sell
-1,627
Closed -$24K 3115
2022
Q4
$24K Buy
1,627
+336
+26% +$5.48K ﹤0.01% 2732
2022
Q3
$21K Sell
1,291
-47
-4% -$946 ﹤0.01% 2750
2022
Q2
$28K Buy
1,338
+748
+127% +$15.3K ﹤0.01% 2555
2022
Q1
$13K Buy
590
+263
+80% +$6.44K ﹤0.01% 2920
2021
Q4
$8K Hold
327
﹤0.01% 3087
2021
Q3
$9K Sell
327
-109
-25% -$3.32K ﹤0.01% 2937
2021
Q2
$13K Buy
436
+115
+36% +$3.39K ﹤0.01% 2673
2021
Q1
$8K Buy
+321
New +$8.22K ﹤0.01% 2692
2020
Q3
Sell
-169
Closed -$3K 2698
2020
Q2
$3K Buy
+169
New +$2.51K ﹤0.01% 2237
2019
Q2
Sell
-128
Closed -$3K 1839
2019
Q1
$3K Buy
+128
New +$4.29K ﹤0.01% 1728

Other funds holding MD

Rockefeller Capital Management's MD Position: Q2 2026 in Review

Rockefeller Capital Management increased its Pediatrix Medical (MD) stake by 76% in Q2 2026, buying an estimated $13.1M and bringing the position to 1,338,592 shares worth $33.9M. The position accounts for 0.05% of the portfolio, ranked #325.

Rockefeller Capital Management first reported a position in MD in Q1 2019 and has held it in 14 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Rockefeller Capital Management held 1,338,592 shares of Pediatrix Medical worth $33.9M as of Q2 2026.
  • Rockefeller Capital Management bought 576,095 Pediatrix Medical shares in Q2 2026, an estimated $13.1M.
  • Pediatrix Medical made up 0.05% of Rockefeller Capital Management's portfolio in Q2 2026, its #325 holding.
  • Rockefeller Capital Management first reported a position in Pediatrix Medical in Q1 2019 and has held it in 14 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.